Cytochrome P450 2A6 (CYP2A6)

[Edit]

CYP2A; CYP2A3; CPA6; CYPIIA6; Cytochrome P450 Family 2 Subfamily A Polypeptide 6; 1,4-cineole 2-exo-monooxygenase; Coumarin 7-hydroxylase

Cytochrome P450 2A6 (CYP2A6)
CYP2A6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to hydroxylate coumarin, and also metabolizes nicotine, aflatoxin B1, nitrosamines, and some pharmaceuticals. Individuals with certain allelic variants are said to have a poor metabolizer phenotype, meaning they do not efficiently metabolize coumarin or nicotine. This gene is part of a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. The gene was formerly referred to as CYP2A3; however, it has been renamed CYP2A6.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Cytochrome P450 2A6 (CYP2A6) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Cytochrome P450 2A6 (CYP2A6) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Cytochrome P450 2A6 (CYP2A6) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Cytochrome P450 2A6 (CYP2A6) CLIA Kit Customized Service Offer
n/a ELISA Kit for Cytochrome P450 2A6 (CYP2A6) ELISA Kit Customized Service Offer
  1. "Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity."Nucleic Acids Res. 17:2907-2917(1989) [PubMed] [Europe PMC] [Abstract]
  2. "cDNA and deduced amino acid sequences of human P450 IIA3 (CYP2A3)."Nucleic Acids Res. 17:4888-4888(1989) [PubMed] [Europe PMC] [Abstract]
  3. "The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes."Biochemistry 29:1322-1329(1990) [PubMed] [Europe PMC] [Abstract]
  4. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  5. "The DNA sequence and biology of human chromosome 19." Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract]
  6. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  7. "Isolation and characterization of a cytochrome P450 of the IIA subfamily from human liver microsomes."Eur. J. Biochem. 200:511-517(1991) [PubMed] [Europe PMC] [Abstract]
  8. "Purification and characterization of human liver microsomal cytochrome P-450 2A6."Mol. Pharmacol. 40:679-685(1991) [PubMed] [Europe PMC] [Abstract]
  9. "CYP2A6*6, a novel polymorphism in cytochrome p450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity."J. Biol. Chem. 276:17830-17835(2001) [PubMed] [Europe PMC] [Abstract]
  10. "Isolation and sequence of a human cytochrome P-450 cDNA clone."Proc. Natl. Acad. Sci. U.S.A. 82:983-987(1985) [PubMed] [Europe PMC] [Abstract]
  11. "Roles of cytochrome P450 3A enzymes in the 2-hydroxylation of 1,4-cineole, a monoterpene cyclic ether, by rat and human liver microsomes."Xenobiotica 31:713-723(2001) [PubMed] [Europe PMC] [Abstract]
  12. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  13. "Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen."Nat. Struct. Mol. Biol. 12:822-823(2005) [PubMed] [Europe PMC] [Abstract]
  14. "Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization."J. Med. Chem. 49:6987-7001(2006) [PubMed] [Europe PMC] [Abstract]
  15. "Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes."Drug Metab. Dispos. 36:2582-2590(2008) [PubMed] [Europe PMC] [Abstract]
  16. "A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin."Food Chem. Toxicol. 35:903-907(1997) [PubMed] [Europe PMC] [Abstract]
  17. "Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism."FEBS Lett. 460:321-327(1999) [PubMed] [Europe PMC] [Abstract]
  18. "A novel single nucleotide polymorphism altering stability and activity of CYP2a6."Biochem. Biophys. Res. Commun. 281:810-814(2001) [PubMed] [Europe PMC] [Abstract]
  19. "Twenty one novel single nucleotide polymorphisms (SNPs) of the CYP2A6 gene in Japanese and Caucasians."Drug Metab. Pharmacokinet. 17:482-487(2002) [PubMed] [Europe PMC] [Abstract]
  20. "Catalog of 680 variations among eight cytochrome p450 (CYP) genes, nine esterase genes, and two other genes in the Japanese population."J. Hum. Genet. 48:249-270(2003) [PubMed] [Europe PMC] [Abstract]
  21. "Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population."Pharmacogenomics 5:895-931(2004) [PubMed] [Europe PMC] [Abstract]
  22. "Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent."Hum. Mutat. 29:679-688(2008) [PubMed] [Europe PMC] [Abstract]
  23. "A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent."Pharmacogenet. Genomics 18:67-75(2008) [PubMed] [Europe PMC] [Abstract]